A new treatment for fish poisoning could be the answer.
It could help ease a severe infection caused by the toxin bovine spongiform encephalopathy (BSE).
For decades, BSE has been found to cause severe neurological symptoms and can cause paralysis and brain damage in the animals.
But a new treatment could help the animals recover.
Scientists at the National Institutes of Health have found that an injection of the toxin in fish can halt BSE infection in the fish, which has the potential to be a big step toward preventing future infections in humans.
Bovine Spongiform Encephalopathy is a neurological disease caused by BSE that affects one in five people in the United States.
In humans, the disease affects a subset of about 1.8 million people in a country of about 10 million.
The scientists found that a single injection of a vaccine containing the BSE protein in a fish treated with the vaccine prevented the animals from developing BSE symptoms, said Dr. Michael E. Krasny, the senior scientist for the Center for Disease Control and Prevention (CDC), at a news conference on Tuesday.
That means that the vaccine could be used to treat people with the disease.
“This is a very significant step forward, and the first of its kind in the animal kingdom,” Dr. Krazy said.
“What this is really about is stopping BSE, because if it’s not stopped, this could be a problem going forward,” he said.
The treatment works by preventing the Bse protein from attaching to the brain cells of the animals, allowing the animals to recover from their infection.
If that was done in humans, it could also be used as a treatment for some types of neurological disorders, including Parkinson’s disease and multiple sclerosis, Dr. Paul B. Volek, an assistant professor of medicine at the University of Arizona, told Reuters Health.
That could be important for people who have the disease or are at risk of developing it, because the disease can affect the immune system.
“It’s a new kind of therapy for humans, so it’s important to understand how it works and where it’s going to work,” Dr, Voleak said.
It’s also important to look for people at increased risk of BSE.
“The main reason for not vaccinating is people who are very old, those who have a high rate of autoimmunity, people who live in areas where there are higher rates of infection,” Dr Voleck said.
If it can be done safely and effectively, the treatment could be available in the U.S. by next year.
Dr. Krakovsky said that the treatment has the chance to help many more people in similar situations than the treatment in humans was.
“We don’t have a vaccine, but we’re moving forward in a very good way.
We’re in a good position to get it to people who would otherwise not have the opportunity,” he told Reuters.
Dr KrasNY also emphasized that this treatment is not a cure.
“People with the illness, it’s a real disability that has been very, very severe,” he added.
“If it were, it would be very difficult for them to go back to work.”
Follow APHealth on Twitter at: @APHealth, @CBSNewsHealth and @CNNHealth for more on this story.